Literature DB >> 2160232

Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase.

J Krause1, W Seydel, G Heinzel, P Tanswell.   

Abstract

Tissue-type plasminogen activator (t-PA) and urokinase (u-PA) are proteins with partial structural similarity and which are of importance in the therapy of thrombotic diseases. Both are known to be cleared from the circulation in vivo by uptake in the liver. The present study investigated whether the hepatic catabolism of u-PA and t-PA is mediated by a common receptor system. Four experimental protocols of increasing complexity were used: hepatocyte plasma membranes, isolated primary hepatocytes, liver perfusion and whole animals. For t-PA, a specific high-affinity binding site to hepatocytes and plasma membranes could be defined with a mean Kd of 4 +/- 3 nM, whereas the Kd for u-PA was less than 300 nM. Binding of t-PA could not be competed for by u-PA, and vice versa. Furthermore, clearance of t-PA in isolated perfused rat livers and in rabbits in vivo was 3-fold higher than that of u-PA, and a 50-100-fold molar excess of u-PA failed to inhibit clearance of t-PA in either system, and vice versa. Taken together, the results imply that hepatic elimination of t-PA and u-PA is mediated by distinct receptor systems of differing affinity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160232      PMCID: PMC1131346          DOI: 10.1042/bj2670647

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Tissue fractionation studies. 4. Comparative study of the binding of acid phosphatase, beta-glucuronidase and cathepsin by rat-liver particles.

Authors:  R GIANETTO; C DE DUVE
Journal:  Biochem J       Date:  1955-03       Impact factor: 3.857

2.  A kinetic method for serum 5'-nucleotidase using stabilised glutamate dehydrogenase.

Authors:  C L Arkesteijn
Journal:  J Clin Chem Clin Biochem       Date:  1976-03

3.  Function and control of liver alkaline phosphatase.

Authors:  J M Pekarthy; J Short; A I Lansing; I Lieberman
Journal:  J Biol Chem       Date:  1972-03-25       Impact factor: 5.157

4.  Isolated perfused rat liver technique.

Authors:  D K Meijer; K Keulemans; G J Mulder
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  The complete amino acid sequence of low molecular mass urokinase from human urine.

Authors:  G J Steffens; W A Günzler; F Otting; E Frankus; L Flohé
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1982-09

6.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

7.  Catabolism of human tissue plasminogen activator in mice.

Authors:  H E Fuchs; H Berger; S V Pizzo
Journal:  Blood       Date:  1985-03       Impact factor: 22.113

8.  Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase.

Authors:  T Ueno; N Kobayashi; T Maekawa
Journal:  Thromb Haemost       Date:  1979-10-31       Impact factor: 5.249

9.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

10.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.

Authors:  J D Vassalli; D Baccino; D Belin
Journal:  J Cell Biol       Date:  1985-01       Impact factor: 10.539

View more
  6 in total

1.  Immunohistological detection of Saruplase (recombinant single-chain urokinase-type plasminogen activator) in normal rat tissue.

Authors:  T Wöhrmann; T Matthiesen; H Beier; L Flohé
Journal:  Histochemistry       Date:  1991

2.  Endocytosis and intracellular processing of tissue-type plasminogen activator by rat liver cells in vivo.

Authors:  E Stang; J Krause; W Seydel; T Berg; N Roos
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

3.  39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.

Authors:  I Warshawsky; G Bu; A L Schwartz
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

4.  Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells.

Authors:  E Stang; N Roos; M Schlüter; T Berg; J Krause
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

5.  Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA.

Authors:  M Otter; J Kuiper; R Bos; D C Rijken; T J van Berkel
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

6.  Characterization of the binding of plasminogen activators to plasma membranes from human liver.

Authors:  G Nguyen; S J Self; C Camani; E K Kruithof
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.